GSK, Uni of California pair up to advance genomic research

 The LGR will receive up to $67 million in funding over a five-year period.

Read on PharmaTimes

Outdated technology systems still ‘limiting’ UK patient care

 Over a third (36%) of respondents’ staff have asked for faster digital technology systems.

Read on PharmaTimes

Rituxan hits endpoints in late-stage skin disease trial

 The drug demonstrated superiority to current standard-of-care to CellCept.

Read on PharmaTimes

ABPI publishes new guidelines on pharma working with patients

 The sourcebook covers six topics, which were identified as areas where further guidance would be of assistance.

Read on PharmaTimes

Gilead, AbCellera team up against infectious diseases

 AbCellera will receive upfront and research payments and is eligible to receive downstream clinical and commercial milestone payments and royalties.

Read on PharmaTimes

1 2 3

Top of page

Industry News

The LGR will receive up to $67 million in funding over a five-year period.
Read More >

More Stories

News

Recent launch of several new categories of compound which include the spirocyclic β-Lactams designed...
Read More >

More Stories

Latest Tweets

Follow Us